跳至主要内容
临床试验/NCT05201300
NCT05201300已完成不适用

Comparison of Remimazolam and Propofol Anesthesia on Hemodynamic and Recovery Profile in Elderly Patients

Ajou University School of Medicine1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2022年2月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
69
试验地点
1
主要终点
difference in the decreased mean arterial pressure

研究概览

简要总结

Remimazolam is a recently developed ultra-short agonist acting at the benzodiazepine binding site of the gamma-aminobutyric acid (GABA)A receptor. Remimazolam has a combination of the hemodynamic stability of benzodiazepines and the advantages of propofol, such as rapid onset, short duration of action, and improved controllability.

A recent study showed that the efficacy of two induction doses of remimazolam (6 and 12 mg/kg/h) as a sedative for general anesthesia was not inferior to propofol (2.0-2.5 mg/kg), and hemodynamically more stable. On the other hand, a study on the emergence time and quality between propofol and remimazolam showed inconsistent results.

The purpose of this study is to compare remimazolam to propofol on the intraoperative hemodynamic changes and recovery profiles, when used in combination with remifentanil in elderly patients undergoing general anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I, II patients over 65 years old undergoing general anesthesia

排除标准

  • cardiac surgery
  • neurosurgery
  • liver surgery
  • uncontrolled hypertension
  • bronchial asthma
  • body mass index ≥ 30 kg/m2
  • severe heart, liver, kidney disease

研究组 & 干预措施

Remimazolam 6

Experimental

Remimazolam starts at 6 mg/kg/hr until loss of consciousness

干预措施: Remimazolam Besylate 6 mg/kg/hr (Drug)

Remimazolam 12

Experimental

Remimazolam starts at 12 mg/kg/hr until loss of consciousness

干预措施: Remimazolam Besylate 12 mg/kg/hr (Drug)

Propofol

Active Comparator

Propofol starts at a target controlled infusion 4 µg/ml until loss of consciousness.

干预措施: Propofol (Drug)

结局指标

主要结局

difference in the decreased mean arterial pressure

时间窗: from the start of anesthetics (propofol or remimazolam) injection to the 5 minutes after extubation

difference between baseline mean arterial pressure and lowest mean arterial pressure

次要结局

未报告次要终点

研究者

发起方
Ajou University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jong Yeop Kim

Professor

Ajou University School of Medicine

研究点 (1)

Loading locations...

相似试验